PD Dr. Jörg Distler

Medizinische Fakultät Professur für Molekulare Mechanismen der Organfibrose

Cutaneous Manifestations, Clinical Characteristics, and Prognosis of Patients with Systemic Sclerosis Sine Scleroderma: Data from the International EUSTAR Database (2023) Lescoat A, Huang S, Carreira PE, Siegert E, De Vries-Bouwstra J, Distler J, Smith V, et al. Journal article Rapid single-cell physical phenotyping of mechanically dissociated tissue biopsies (2023) Soteriou D, Kubankova M, Schweitzer C, Lopez Posadas R, Pradhan R, Thoma OM, Györfi AH, et al. Journal article Activation of the alpha7 nicotinic acetylcholine receptor ameliorates skin fibrosis and reduces TGF-beta1-induced collagen synthesis in human dermal fibroblasts by modulating JunB (2023) Stegemann A, Dreissigacker K, Summa L, Flis D, Distler J, Ziolkowski W, Steinbrink K, Boehm M Conference contribution Identification of a Distinct Monocyte-Driven Signature in Systemic Sclerosis Using Biophysical Phenotyping of Circulating Immune Cells (2023) Matei AE, Kubankova M, Xu L, Györfi AH, Boxberger E, Soteriou D, Papava M, et al. Journal article Treatment of a patient with severe systemic sclerosis (SSc) using CD19-targeted CAR T cells. (2023) Bergmann C, Müller F, Distler J, Györfi AH, Völkl S, Aigner M, Kretschmann S, et al. Journal article, Letter The Exciting Future for Scleroderma: What Therapeutic Pathways Are on the Horizon? (2023) Distler J, Riemekasten G, Denton CP Journal article, Review article Assessment of myocardial fibrosis in patients with systemic sclerosis using [Ga-68]Ga-FAPI-04-PET-CT (2022) Treutlein C, Distler J, Tascilar K, Chenguiti Fakhouri S, Györfi AH, Atzinger A, Matei AE, et al. Journal article Dersimelagon, a novel oral melanocortin 1 receptor agonist, demonstrates disease-modifying effects in preclinical models of systemic sclerosis (2022) Kondo M, Suzuki T, Kawano Y, Kojima S, Miyashiro M, Matsumoto A, Kania G, et al. Journal article Dynamic changes in O-GlcNAcylation regulate osteoclast differentiation and bone loss via nucleoporin 153 (2022) Li YN, Chen CW, Trinh MT, Zhu H, Matei AE, Györfi AH, Kuwert F, et al. Journal article Decline in forced vital capacity in subjects with systemic sclerosis-associated interstitial lung disease in the SENSCIS trial compared with healthy reference subjects (2022) Maher TM, Bourdin A, Volkmann ER, Vettori S, Distler J, Alves M, Stock C, Distler O Journal article